|
Program Overview:
Cardiometabolic disease, which includes diabetes, obesity and coronary artery disease, kills well over 1 million people in our country each year. The importance of this learning activity is highlighted by the fact that it will serve as an overview to understand how obesity, insulin resistance, and Diabetes Type 2 relates to cardiovascular risk. Also included will be a discussion on emerging cardiovascular biomarkers and risk sensitivity. Pharmacologic and non-pharmacologic prevention and treatment strategies will be discussed in some detail as well. Lastly, patient education and counseling strategies will be addressed which will be followed up with a live 15 minute question and answer session involving all participants.
|